学术探索
学术期刊
新闻热点
数据分析
智能评审
立即登录
INVESTIGATION OF THE STABILITY OF DOXORUBICIN HYDROCHLORIDE USING FACTORIAL DESIGN
被引:16
作者
:
GUPTA, PK
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV OTAGO,DEPT PHARM,DUNEDIN,NEW ZEALAND
GUPTA, PK
LAM, FC
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV OTAGO,DEPT PHARM,DUNEDIN,NEW ZEALAND
LAM, FC
HUNG, CT
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV OTAGO,DEPT PHARM,DUNEDIN,NEW ZEALAND
HUNG, CT
机构
:
[1]
UNIV OTAGO,DEPT PHARM,DUNEDIN,NEW ZEALAND
[2]
UNIV OTAGO,DEPT MATH & STAT,DUNEDIN,NEW ZEALAND
来源
:
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
|
1988年
/ 14卷
/ 12期
关键词
:
D O I
:
10.3109/03639048809151980
中图分类号
:
R914 [药物化学];
学科分类号
:
100701 ;
摘要
:
引用
收藏
页码:1657 / 1671
页数:15
相关论文
共 28 条
[1]
[Anonymous], 1976, MERCK INDEX, V9th
[2]
ADRIAMYCIN - NEW ANTICANCER DRUG WITH SIGNIFICANT CLINICAL ACTIVITY
BLUM, RH
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, DIV CANC TREATMENT, BETHESDA, MD 20014 USA
NCI, DIV CANC TREATMENT, BETHESDA, MD 20014 USA
BLUM, RH
CARTER, SK
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, DIV CANC TREATMENT, BETHESDA, MD 20014 USA
NCI, DIV CANC TREATMENT, BETHESDA, MD 20014 USA
CARTER, SK
[J].
ANNALS OF INTERNAL MEDICINE,
1974,
80
(02)
: 249
-
259
[3]
FACTORIAL-DESIGNS IN PHARMACEUTICAL STABILITY STUDIES
BOLTON, S
论文数:
0
引用数:
0
h-index:
0
BOLTON, S
[J].
JOURNAL OF PHARMACEUTICAL SCIENCES,
1983,
72
(04)
: 362
-
366
[4]
BOWEN J, 1981, P AM ASSOC CANC RES, V22, P354
[5]
BOX GEP, 1978, STATISTICS EXPT
[6]
ADRIAMYCIN - REVIEW
CARTER, SK
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,BETHESDA,MD 20014
NCI,DIV CANC TREATMENT,BETHESDA,MD 20014
CARTER, SK
[J].
JOURNAL OF THE NATIONAL CANCER INSTITUTE,
1975,
55
(06)
: 1265
-
1274
[7]
Davies L., 1993, DESIGN ANAL IND EXPT
[8]
DIMARCO A, 1969, CANCER CHEMOTH REP 1, V53, P33
[9]
REVERSED-PHASE ION-PAIR HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY OF ADRIAMYCIN AND ADRIAMYCINOL IN RAT SERUM AND TISSUES
GALLO, JM
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV OTAGO,DEPT PHARM,DUNEDIN,NEW ZEALAND
UNIV OTAGO,DEPT PHARM,DUNEDIN,NEW ZEALAND
GALLO, JM
HUNG, CT
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV OTAGO,DEPT PHARM,DUNEDIN,NEW ZEALAND
UNIV OTAGO,DEPT PHARM,DUNEDIN,NEW ZEALAND
HUNG, CT
PERRIER, DG
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV OTAGO,DEPT PHARM,DUNEDIN,NEW ZEALAND
UNIV OTAGO,DEPT PHARM,DUNEDIN,NEW ZEALAND
PERRIER, DG
[J].
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS,
1986,
4
(04)
: 483
-
490
[10]
GUPTA P, UNPUB
←
1
2
3
→
共 28 条
[1]
[Anonymous], 1976, MERCK INDEX, V9th
[2]
ADRIAMYCIN - NEW ANTICANCER DRUG WITH SIGNIFICANT CLINICAL ACTIVITY
BLUM, RH
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, DIV CANC TREATMENT, BETHESDA, MD 20014 USA
NCI, DIV CANC TREATMENT, BETHESDA, MD 20014 USA
BLUM, RH
CARTER, SK
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, DIV CANC TREATMENT, BETHESDA, MD 20014 USA
NCI, DIV CANC TREATMENT, BETHESDA, MD 20014 USA
CARTER, SK
[J].
ANNALS OF INTERNAL MEDICINE,
1974,
80
(02)
: 249
-
259
[3]
FACTORIAL-DESIGNS IN PHARMACEUTICAL STABILITY STUDIES
BOLTON, S
论文数:
0
引用数:
0
h-index:
0
BOLTON, S
[J].
JOURNAL OF PHARMACEUTICAL SCIENCES,
1983,
72
(04)
: 362
-
366
[4]
BOWEN J, 1981, P AM ASSOC CANC RES, V22, P354
[5]
BOX GEP, 1978, STATISTICS EXPT
[6]
ADRIAMYCIN - REVIEW
CARTER, SK
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,BETHESDA,MD 20014
NCI,DIV CANC TREATMENT,BETHESDA,MD 20014
CARTER, SK
[J].
JOURNAL OF THE NATIONAL CANCER INSTITUTE,
1975,
55
(06)
: 1265
-
1274
[7]
Davies L., 1993, DESIGN ANAL IND EXPT
[8]
DIMARCO A, 1969, CANCER CHEMOTH REP 1, V53, P33
[9]
REVERSED-PHASE ION-PAIR HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY OF ADRIAMYCIN AND ADRIAMYCINOL IN RAT SERUM AND TISSUES
GALLO, JM
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV OTAGO,DEPT PHARM,DUNEDIN,NEW ZEALAND
UNIV OTAGO,DEPT PHARM,DUNEDIN,NEW ZEALAND
GALLO, JM
HUNG, CT
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV OTAGO,DEPT PHARM,DUNEDIN,NEW ZEALAND
UNIV OTAGO,DEPT PHARM,DUNEDIN,NEW ZEALAND
HUNG, CT
PERRIER, DG
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV OTAGO,DEPT PHARM,DUNEDIN,NEW ZEALAND
UNIV OTAGO,DEPT PHARM,DUNEDIN,NEW ZEALAND
PERRIER, DG
[J].
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS,
1986,
4
(04)
: 483
-
490
[10]
GUPTA P, UNPUB
←
1
2
3
→